To view this email as a web page, click here

Today's Rundown

Featured Story

GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Fierce 15 winner Ideaya

As GlaxoSmithKline looks to deepen its cancer R&D, it's penned an oncology development program with Ideaya Biosciences.

read more

Top Stories

With hard cash from U.K., Imperial to kick-start next-gen COVID-19 vaccine trials this month

As the U.S., Germany and France start funneling more cash into their life sciences for a solution to the COVID-19 problem, the U.K. is following suit with a new type of vaccine.

read more

Nominations for Fierce Biotech's 2020 Fierce 15

So many people see innovation as a given: It happens in the background, takes a good few years and usually comes together with more than a little luck. We don’t see the toil and failure, we see and demand just the final result. If I feel ill, I go to the doctor and ask for medicine, and, most of the time, that will just be there to make me well.

read more

Sponsored: The Future of Clinical Research: Digitally Transforming What’s Possible

Sponsors are transforming and future-proofing their clinical research by incorporating virtual options in study protocols. Discover why patients are key to the success of these digital strategies.

read more

Inventiva’s NASH hopeful cuts inflammation, scarring in phase 2

Inventiva’s NASH prospect beat placebo at cutting liver inflammation in patients with NASH without making their scarring worse, hitting its primary endpoint in a phase 2b study. The data offer hope for a class of drugs that has been dogged with failure and could set Inventiva’s drug up for accelerated approvals.

read more

ETheRNA nabs €34M for mRNA vaccines—including COVID-19 candidate

Belgium’s eTheRNA picked up €34 million ($38 million) to bankroll the development of its mRNA technologies as well as a suite of mRNA immunotherapies for cancer and infectious diseases, including a program against SARS-CoV-2, the virus that causes COVID-19.

read more

Ona raises €30M to treat metastases by blocking fat intake

Ona Therapeutics has raised a €30 million ($34 million) series A round to take biologics that treat metastatic cancer into clinical trials. The R&D plan is underpinned by early evidence that antibodies can stop metastasis-initiating cells from supporting the spread of tumors around the body.

read more

FDA clears its first prescription video game treatment for ADHD

The FDA has cleared its first video game for children with attention deficit hyperactivity disorder, allowing Akili Interactive’s EndeavorRx to be prescribed as a digital therapeutic.

read more

Trial disruption easing, but fallout will linger: report

As CROs and biopharmas adapt to virtual trials and conducting tests amid a pandemic, some studies are back up and running, but future approvals will be hit by last quarter’s chaos.

read more

China's Sinopharm touts 100% antibody response for COVID-19 vaccine it's already giving to workers

China's state-run Sinopharm said one of its inactivated COVID-19 vaccines triggered a strong neutralizing antibody response in a phase 1/2 study. And even as the design of a phase 3 trial is still under wraps, the company is reportedly offering the experimental vaccine to employees at state-owned companies who intend to travel overseas.

read more

Enrollment Showcase

A Credential for the Future of Health Care

Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program.

Resources

Case Study: Pharma Sponsor Enlists Cenduit to Rescue a Multi-Country, Multi-Site Oncology Study

Download this case study to read how Cenduit helped one client successfully navigate mid-study changes to medication management.

Whitepaper: 4 Ways to Keep Pace with Big Pharma, Even On a Start-Up Budget

Learn four ways to squeeze more value from your limited R&D resources.

eBook: Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies

Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies

Whitepaper: Brand Revitalization with RP Scherer Softgel Solutions for Analgesics

In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. Learn more.

Whitepaper: 7 Keys to Success in Europe

White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe.

Whitepaper: Rapid BYOD Build Timelines

This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations.

Whitepaper: Keep Your GI Trials Moving During COVID-19

Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19.

Whitepaper: The Evolution and Importance of Biomedical Ontologies for Scientific Literature

Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases.

Whitepaper: Pandemic respiratory vaccine clinical trials: a departure from business as usual

Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency.

Case Study: Establishing Parameters for Success

Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study.

Fact Sheet: Forecasting to Optimize Clinical Trial Supply Management

Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study.

eBook: Expecting the Unexpected: Strategies for Efficient Clinical Supply Management and Forecasting

Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study.

Case Study: Precision Analytics for Product Launch and Growth

Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. 

Virtual Event: Cardiac Safety London Online

Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research.

Whitepaper: Why Your Business Needs An Effective Cloud Strategy To Survive Now

Businesses must maintain pre-pandemic levels of productivity with smaller IT budgets. Learn why an effective Cloud Strategy is imperative for success in these unprecedented times.

Events